Document is current
Any future updates will be listed below
-
Authors
Makhmudova, Umidakhon
Schatz, Ulrike
Stuerzebecher, Paulina
Schumann, Friederike
Kästner, Uta
Mensch, Juliane
Geiling, Jens Arndt
Haertel, Franz
Stach, Ksenija
Vogt, Anja
Bässler, Andrea
Sinning, David
Kassner, Ursula
Steinhagen-Thiessen, Elisabeth
Schulze, P. Christian
Landmesser, Ulf
Laufs, Ulrich
Weingärtner, Oliver https://orcid.org/0000-0002-0236-206X
-
Funding
Funding for this research was provided by:
Universitätsklinikum Jena
- License Information
-
More Information
Article History
Received: 14 May 2026
Accepted: 10 September 2026
First Online: 28 September 2026
Declarations
Conflict of interest: J.M. reports speaker fee from Novartis, non-financial support from Novartis, Sanofi and Roche Diagnostics. A.V. reports speaker fees and/or advisory board honoraria from Aegerion, Akcea, Amgen, Amryt, Berlin Chemie, Chiesi, Daiichi Sankyo, MSD, Novartis, Regeneron/Sanofi. D.S. reports speaker fees from Novartis, Daiichi Sankyo und Amgen. U.K. reports fees from Amgen, Daiichi Sankyo, Novartis, Regeneron/Sanofi. E.S-T. reports fees for lectures and/or advisory board honoraria from Fresenius Medical Care. Daiichi-Sankyo, Novartis, Amgen, Amarin, Sanofi, Pfizer. U.L. reports fees from Novartis, Daiichi Sankyo, Amgen, Sanofi. O.W. reports fees from Novartis, Daiichi Sankyo, Amgen, Sanofi, Fresenius, Novo Nordisk, Hexal, Akcea Therapeutics, Sobi and Pfizer. All reported conflicts of interest are outside the submitted work.
